Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

HIV and mitochondrial toxicity in children.

Foster C, Lyall H.

J Antimicrob Chemother. 2008 Jan;61(1):8-12. Epub 2007 Nov 13. Review.

PMID:
17999978
2.

A brief overview of mechanisms of mitochondrial toxicity from NRTIs.

Kohler JJ, Lewis W.

Environ Mol Mutagen. 2007 Apr-May;48(3-4):166-72. Review.

PMID:
16758472
3.
5.

Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?

de Mendoza C, Sanchez-Conde M, Ribera E, Domingo P, Soriano V.

AIDS Rev. 2004 Jul-Sep;6(3):169-80. Review.

PMID:
15595434
6.

Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring and management.

Cherry CL, Lala L, Wesselingh SL.

Sex Health. 2005;2(1):1-11. Review.

PMID:
16334706
7.

Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy.

Lewis W.

Prog Cardiovasc Dis. 2003 Jan-Feb;45(4):305-18. Review.

PMID:
12638094
8.
9.

[Impact of reverse transcriptase inhibitors on sperm mitochondrial and genomic DNA in assisted reproduction techniques].

Sergerie M, Martinet S, Kiffer N, Teulé R, Pasquier C, Bujan L.

Gynecol Obstet Fertil. 2004 Oct;32(10):841-9. Review. French.

PMID:
15501159
10.

Animal models of anti-HIV drugs exposure during pregnancy: effects on neurobehavioral development.

Venerosi A, Calamandrei G, Alleva E.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):747-61. Review.

PMID:
12188107
11.

Mitochondrial toxicity: myths and facts.

Moyle G.

J HIV Ther. 2004 May;9(2):45-7. Review.

PMID:
15238876
12.

Mitochondrial disease in the offspring as a result of antiretroviral therapy.

Venhoff N, Walker UA.

Expert Opin Drug Saf. 2006 May;5(3):373-81. Review.

PMID:
16610967
13.

Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.

Thorne C, Newell ML.

Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):425-36. Review.

PMID:
15010553
14.

Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children.

Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):290-6. doi: 10.1097/QAI.0b013e318221c56a. Review.

PMID:
21602695
15.

Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.

Lewis W.

Antivir Ther. 2005;10 Suppl 2:M13-27. Review.

PMID:
16152703
16.

Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation.

Feeney ER, Mallon PW.

Curr Pharm Des. 2010 Oct;16(30):3339-51. Review.

PMID:
20687890
17.

Metabolic complications associated with antiretroviral therapy in HIV-infected and HIV-exposed uninfected paediatric patients.

Viganò A, Cerini C, Pattarino G, Fasan S, Zuccotti GV.

Expert Opin Drug Saf. 2010 May;9(3):431-45. doi: 10.1517/14740330903579991. Review.

PMID:
20078250
18.

Update on mitochondrial toxicity: where are we now?

Walker UA.

J HIV Ther. 2003 May;8(2):32-5. Review.

PMID:
12838162
19.
20.

Supplemental Content

Support Center